Keywords: Merck & Co, Health care reform, Medicaid, Datamonitor, Sales impact

Merck & Co foresees $300-$350 million hit from US health care reform legislation in 2011; Datamonitor views impact on others

Article | 26 April 2010

Print This

US drug major Merck & Co, which is scheduled to report first quarter results on May 4, says that, with the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in